Literature DB >> 16800863

TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors.

Min Liu1, Wenlong Huang, Dongsheng Wu, John V Priestley.   

Abstract

We examined the importance of membrane cholesterol for the function and expression of TRPV1 (vanilloid receptor subtype 1) and P2X(3) in adult rat dorsal root ganglion (DRG) neurons. Cholesterol, an essential component of lipid rafts, was depleted using methyl beta-cyclodextrin (MCD). We found that MCD significantly reduced TRPV1-mediated capsaicin- and proton-activated currents. By contrast, inward currents activated by alpha,beta-methylene ATP (alpha,beta-meATP), a non-hydrolysable ATP analogue, were not altered. Immunoreactivity for TRPV1, but not P2X(3), in the plasma membrane was markedly reduced by MCD. A reduction of TRPV1 protein in membrane fractions was found following cholesterol depletion. Our data show that the level of cholesterol determines the activity and the amount of membrane TRPV1, suggesting that TRPV1 might be localized in cholesterol-rich microdomains in nociceptors. The differential dependence on the membrane cholesterol of TRPV1 and P2X(3) may have physiological significance in nociception during inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800863     DOI: 10.1111/j.1460-9568.2006.04889.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  53 in total

1.  Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.

Authors:  Irina Vetter; Wei Cheng; Madusha Peiris; Bruce D Wyse; Sarah J Roberts-Thomson; Jie Zheng; Gregory R Monteith; Peter J Cabot
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 2.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 3.  Regulation of thermoTRPs by lipids.

Authors:  Sara L Morales-Lázaro; Luis Lemus; Tamara Rosenbaum
Journal:  Temperature (Austin)       Date:  2016-11-01

Review 4.  Structural insights into the gating mechanisms of TRPV channels.

Authors:  Ruth A Pumroy; Edwin C Fluck; Tofayel Ahmed; Vera Y Moiseenkova-Bell
Journal:  Cell Calcium       Date:  2020-01-24       Impact factor: 6.817

Review 5.  P2X receptor channels in chronic pain pathways.

Authors:  Louis-Philippe Bernier; Ariel R Ase; Philippe Séguéla
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

6.  Lipid raft segregation modulates TRPM8 channel activity.

Authors:  Cruz Morenilla-Palao; María Pertusa; Víctor Meseguer; Hugo Cabedo; Félix Viana
Journal:  J Biol Chem       Date:  2009-01-27       Impact factor: 5.157

7.  Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages.

Authors:  P Sanjai Kumar; Tapas K Nayak; Chandan Mahish; Subhransu S Sahoo; Anukrishna Radhakrishnan; Saikat De; Ankita Datey; Ram P Sahu; Chandan Goswami; Soma Chattopadhyay; Subhasis Chattopadhyay
Journal:  Arch Virol       Date:  2020-10-30       Impact factor: 2.574

8.  Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief.

Authors:  G Jancsó; M Dux; O Oszlács; P Sántha
Journal:  Br J Pharmacol       Date:  2008-11-10       Impact factor: 8.739

Review 9.  The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1).

Authors:  Sara L Morales-Lázaro; Sidney A Simon; Tamara Rosenbaum
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

10.  Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors.

Authors:  Rebecca C Allsopp; Ulyana Lalo; Richard J Evans
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.